Literature DB >> 32696838

Should all COVID-19 patients be approached in the same way?

Caio Julio Cesar Dos Santos Fernandes1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32696838      PMCID： PMC7567620          DOI： 10.36416/1806-3756/e20200218

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  10 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Current Drugs with Potential for Treatment of COVID-19: A Literature Review.

Authors: 
Journal:  J Pharm Pharm Sci       Date:  2020       Impact factor: 2.327

3.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

Authors:  Ning Tang; Huan Bai; Xing Chen; Jiale Gong; Dengju Li; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-04-27       Impact factor: 5.824

4.  COVID-19 pneumonia: what is the role of imaging in diagnosis?

Authors:  Jose de Arimateia Batista Araujo-Filho; Marcio Valente Yamada Sawamura; André Nathan Costa; Giovanni Guido Cerri; Cesar Higa Nomura
Journal:  J Bras Pneumol       Date:  2020-03-27       Impact factor: 2.624

5.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

Review 6.  Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis.

Authors:  Brandon Michael Henry; Jens Vikse; Stefanie Benoit; Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Clin Chim Acta       Date:  2020-04-26       Impact factor: 3.786

7.  COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; Silvia Coppola; Massimo Cressoni; Mattia Busana; Sandra Rossi; Davide Chiumello
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

8.  Presentation of pulmonary infection on CT in COVID-19: initial experience in Brazil.

Authors:  Rodrigo Caruso Chate; Eduardo Kaiser Ururahy Nunes Fonseca; Rodrigo Bastos Duarte Passos; Gustavo Borges da Silva Teles; Hamilton Shoji; Gilberto Szarf
Journal:  J Bras Pneumol       Date:  2020-04-09       Impact factor: 2.624

9.  Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19.

Authors:  Marisa Dolhnikoff; Amaro Nunes Duarte-Neto; Renata Aparecida de Almeida Monteiro; Luiz Fernando Ferraz da Silva; Ellen Pierre de Oliveira; Paulo Hilário Nascimento Saldiva; Thais Mauad; Elnara Marcia Negri
Journal:  J Thromb Haemost       Date:  2020-06       Impact factor: 16.036

10.  D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.

Authors:  Litao Zhang; Xinsheng Yan; Qingkun Fan; Haiyan Liu; Xintian Liu; Zejin Liu; Zhenlu Zhang
Journal:  J Thromb Haemost       Date:  2020-06       Impact factor: 16.036
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.